Immune Profile and Network Analysis of Malaria Infection and Vaccination
Immune Profile and Network Analysis of Malaria Infection and Vaccination
批准号:
9129262
负责人:
Margaret Juliana McElrath
金额:
$24.63万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-29 至 2017-08-31
关键词:
AdultAffectAfricanAntibody ResponseAntigensAntimalarialsBiometryBreedingCharacteristicsChildClinicalClinical TrialsCommunitiesCountryDNADataDevelopmentFoundationsGenetic TranscriptionGoalsGrantImmuneImmune responseImmune systemImmunityImmunizationImmunologyInfectionInformaticsInstitutionIntegration Host FactorsLaboratoriesLeadLeukocytesLifeMalariaMalaria VaccinesMethodologyMolecular ProfilingNatural ImmunityParasitesPathway AnalysisPhasePhenotypePlasmodium falciparumPopulationPopulation StudyProcessResearchResearch DesignResearch PersonnelSamplingSpecificitySterilityStrategic PlanningSystems BiologyTechnologyTimeVaccinationVaccinescell typechemokinecytokinedesignimmune functionimprovedinsightprogramsresponsetrial designvaccine developmentvaccine efficacyvaccine trial
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): It Is an opportune time for malaria vaccine (development with the first indication of vaccine efficacy and the promise of very effective vaccines in trials that are underway, planned for the coming year, and poised to enter phase 1/2a clinical trials during the grant period. A consortium of committed experts from strong institutions and with complementary expertise in malaria, immunology, systems biology, vaccines, and biostatistics has assembled to use the available trial samples in order to characterize in detail antimalarial immune responses and their relationship to immune protection. This opportunity attracted the enthusiastic participation of those who are conducting vaccine trials and who will provide the clinical samples. The design of these trials supports comprehensive immune profiling and network analysis assessment. Samples will be obtained prior to and following vaccination and challenge or natural infection from study populations that span malaria-naive adults to children and adults living in endemic regions. The P. falciparum parasites range from well characterized clinical isolates (e.g. NF54) to biodiverse natural populations in several African countries. The project will use a wide range of best-of-breed methodologies to characterize a wide range of immune responses and immune cell types. This includes multi-parametric assessments of malaria specific leukocyte phenotypes, cytokine and chemokine profiles, antibody responses, and transcriptional and host DNA analyses. This is designed to generate a profiles of immune responses that can in a systems biology approach be correlated with immune status and mechanisms and identify functional networks associated with immune protection. The study is designed to provide insight into protective immune mechanisms to malaria in order to improve anti-malarial vaccines and also to lay a foundation for improved vaccine development in general that can be shared with the community.
RELEVANCE: A consortium of investigators with complementary expertise that span a wide range of high-end laboratory and informatic technologies have joined forces to comprehensively profile immune responses to malaria infection and the development of immunity. The overall goal of this project is to elucidate the mechanisms of immune protection to malaria in order to accelerate development of a broadly effective malaria vaccine and to advance the process of vaccine development in general.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
CoVPN 3003 A Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older LC 3
-
批准号:10570748
-
项目类别:
-
资助金额:$58.69万
-
财政年份:2022
-
负责人:Margaret Juliana McElrath
-
依托单位:
HVTN 405/HPTN 1901 (CoVPN) Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals: LC 3
-
批准号:10570806
-
项目类别:
-
资助金额:$132.48万
-
财政年份:2022
-
负责人:Margaret Juliana McElrath
-
依托单位:
CoVPN 3004 - A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine Lab
-
批准号:10322580
-
项目类别:
-
资助金额:$1498.01万
-
财政年份:2021
-
负责人:Margaret Juliana McElrath
-
依托单位:
HVTN 405/HPTN 1901 Characterizing SARS-CoV-2-specific immunity in convalescent individuals: LC
-
批准号:10165321
-
项目类别:
-
资助金额:$2995.23万
-
财政年份:2020
-
负责人:Margaret Juliana McElrath
-
依托单位:
SARS-CoV-2 testing at the Seattle Vaccine and Prevention CRS (30331)
-
批准号:10166485
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2020
-
负责人:Margaret Juliana McElrath
-
依托单位:
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization - Clinical Core
-
批准号:10419582
-
项目类别:
-
资助金额:$17.68万
-
财政年份:2017
-
负责人:Margaret Juliana McElrath
-
依托单位:
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization
-
批准号:10419580
-
项目类别:
-
资助金额:$207.15万
-
财政年份:2017
-
负责人:Margaret Juliana McElrath
-
依托单位:
Scientific Project 2: HIV AIDS Defining molecular signatures in humans following vaccination that can inform pathways to protective immunity against HIV-1 infection
-
批准号:10419585
-
项目类别:
-
资助金额:$20.45万
-
财政年份:2017
-
负责人:Margaret Juliana McElrath
-
依托单位:
Immune Responses to Malaria and HIV Infection and Immunization - Clinical Core
-
批准号:10198679
-
项目类别:
-
资助金额:$16.28万
-
财政年份:2017
-
负责人:Margaret Juliana McElrath
-
依托单位:
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization - Clinical Core
-
批准号:10631089
-
项目类别:
-
资助金额:$18.52万
-
财政年份:2017
-
负责人:Margaret Juliana McElrath
-
依托单位:
Immune responses to HIV virus immunization - Project 2
-
批准号:10198682
-
项目类别:
-
资助金额:$59.64万
-
财政年份:2017
-
负责人:Margaret Juliana McElrath
-
依托单位:
Scientific Project 2: HIV AIDS Defining molecular signatures in humans following vaccination that can inform pathways to protective immunity against HIV-1 infection
-
批准号:10631105
-
项目类别:
-
资助金额:$13.48万
-
财政年份:2017
-
负责人:Margaret Juliana McElrath
-
依托单位:
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization
-
批准号:10631086
-
项目类别:
-
资助金额:$210.0万
-
财政年份:2017
-
负责人:Margaret Juliana McElrath
-
依托单位:
HIV-1 Cellular Immunity in Exposed Seronegatives
-
批准号:8086448
-
项目类别:
-
资助金额:$18.49万
-
财政年份:2010
-
负责人:Margaret Juliana McElrath
-
依托单位:
Immune Profile and Network Analysis of Malaria Infection and Vaccination
-
批准号:8150942
-
项目类别:
-
资助金额:$51.81万
-
财政年份:2010
-
负责人:Margaret Juliana McElrath
-
依托单位:
Immune Signatures Associated with Plasmodium falciparum Control Following Natural
-
批准号:7994286
-
项目类别:
-
资助金额:$28.66万
-
财政年份:2010
-
负责人:Margaret Juliana McElrath
-
依托单位:
Immune Profile and Network Analysis of Malaria Infection and Vaccination
-
批准号:7977154
-
项目类别:
-
资助金额:$52.3万
-
财政年份:2010
-
负责人:Margaret Juliana McElrath
-
依托单位:
Immune Profile and Network Analysis of Malaria Infection and Vaccination
-
批准号:8527698
-
项目类别:
-
资助金额:$48.2万
-
财政年份:2010
-
负责人:Margaret Juliana McElrath
-
依托单位:
Immune Profile and Network Analysis of Malaria Infection and Vaccination
-
批准号:8316314
-
项目类别:
-
资助金额:$51.28万
-
财政年份:2010
-
负责人:Margaret Juliana McElrath
-
依托单位:
Seattle-Lausanne Clinical Trials Unit
-
批准号:10531278
-
项目类别:
-
资助金额:$185.72万
-
财政年份:2007
-
负责人:Margaret Juliana McElrath
-
依托单位:
海外基金